Background: During the last two decades a major increase in the proportion of severe fungal infections has been noted due to the excessive use of broad-spectrum antibiotics, catheters, and a growing number of immunocompromised patients.
Introduction
The fourth source of bloodstream infections as prevalence, Candida yeasts remain the most recurrent fungal pathogen in humans [1] . C. albicans is the most frequent species causing mortality rates of 50% [2] [3] . C. albicans is a member of the normal human microbiome, usually being commensal and harmless, but under certain circumstances, it becomes an opportunistic pathogen and produces candidiasis if the defence mechanisms of the host are damaged [4] .
Candida infections are a major health issue supplied, paradoxically, by the improvements in medical care, where the most important predisposing factors for the infections are the use of antibiotics, indwelling catheters, immunosuppression, chemotherapy and radiotherapy [5] [6] [7] . C. albicans produces two major types of infections: superficial infections, such as oral or vaginal candidiasis, and deep-seated life-threatening systemic infections (such as Candida endocarditis and acute invasive candidiasis as causes of sepsis) [8] .
Several factors that contribute to the pathogenic potential of this fungus have been identified such as biofilm formation, the secretion of hydrolases, contact sensing and thigmotropism and phenotypic switching [9] . Understanding how these mechanisms and factors contribute to infection has significantly increased during the last years, but at the same time, new virulence strategies have recently been observed.
Antifungal therapy is a critical component of the patient management for acute and chronic diseases [10] . The presence of oral Candida yeasts is considered a signal indicative of immune system impairment and can be correlated with a progressive disease [11] .
Oral candidiasis is one of the most frequent types of Candida infection found especially in denture wearers and individuals with severe conditions (e.g. HIV-infected patients), patients under antibiotic or chemotherapy, and patients with systemic diseases such as diabetes [12] . HIV-infected patients are passible to mycoses as cell-mediated immunity decays [12] .
In diabetic patients, hyperglycaemia can favour several infectious diseases ranging from superficial candidiasis to deep-seated mycoses [13] . Because of the poor immune system, oral candidiasis development is often faster and more severe [10] . Candidemia incidence is statistically correlated with hyperglycaemia and is a serious mortality cause in patients with diabetes [14] .
Candida has the ability to produce various virulence factors that amplify their property to colonize mucosal or synthetic surfaces and, afterwards, to invade the host tissues. Studies regarding isolates from people with candidemia are more numerous and to our knowledge, the present study is the first investigation providing complete data regarding the phenotypic and genotypic profiles of C. albicans strains isolated in Romanian patients.
We report a screening of 301 clinical yeast isolates in terms of phenotypic and genotypic profiles: genotype determination (G), resistogram (R), phospholipase activity (Pl), haemolysis (Hl), proteinase activity (Pt) and biofilm formation (BF) in order to investigate the relationship between C. albicans strains and their pathogenicity.
Material and methods

Clinical isolate processing
Three-hundred and one C. albicans clinical isolates were collected in four tertiary hospitals from different regions of Romania (i.e. Iași, Cluj-Napoca, Timișoara, and Tîrgu Mureș). Samples were recovered from bloodstream infections (BSI), deep-seated mycoses (DEEP) (lower respiratory tract, peritoneal cavity, upper urinary tract in non-catheterized patients, and cerebrospinal fluid) and superficial mycoses (SUP) (female genital tract, oropharyngeal, and gastro-intestinal tract). The isolates were collected from patients who presented at the same time at least two of the following risk factors: low birth weight (<1500 g), old age (>65 years), insulin-dependent diabetes mellitus, recent major surgery, broad-spectrum antibiotic therapy, central venous catheter, organ transplantation, immunosuppression (HIV infection or other predisposing conditions), total parenteral nutrition or mechanical ventilation.
The isolates were presumptively identified by local hospital laboratories and then submitted to the Laboratory of Antimicrobial Chemotherapy from the Department of Public Health of "Ion Ionescu de la Brad" University, Iași, Romania. The last identification was performed using ID32C strips (bioMérieux, France). Isolates identified as C. albicans were also tested using duplex PCR by a method previously described by Romeo & Criseo [15] .
C. albicans genotype determination (G) by Polymerase Chain Reaction (PCR)
In order to extract DNA, two colonies of C. albicans were taken from Sabouraud Dextrose Agar (SDA) plates and suspended in 200 µl sterile distilled water in a sterile Eppendorf tube. DNA was obtained by lysing the cells at 95°C for 5 min and by immersing in ice. PCR was performed according to the method previously described [16] [17] using the primers CA-NT-L (5'-ATAAGGGAAGTCGGCAAAATAGATC-CGTAA-3') and CA-NT-R (5'-CCTTGGCT-GTGGTTTCGCTAGATAGTAGAT-3'). The products were analysed by electrophoresis on 1.5% agarose gels in Tris-borate-EDTA (TBE) buffer at 70 V for 30 min and were subsequently stained in a solution of 0.5 μg of ethidium bromide per mL.
According to the PCR products, the genotypes of C. albicans can be classified by the size of DNA amplified into 3 groups: 450 bp for group A, 840 bp for group B, 450 and 840 bp for group C) [17] [18] [19] . [20] , with a few modifications [21] . The plates containing chemicals at different concentrations (mg/mL Sabouraud dextrose agar) used for the resistogram typing were: sodium selenite: 0. [20] . After incubation for 40 h at 37ºC, the growth of each strain was read. For example, the resistogram "AB --E" signifies that the tested strain was resistant to sodium selenite (A), boric acid (B) and silver nitrate (E), but sensitive to cetrimide (-) and sodium periodate (-) [21] .
Resistogram (R). The resistogram typing of the isolates of C. albicans was performed according to McCreight and Warnock method
Phospholipase activity assays (Pl). Extracellular phospholipase activity was evaluated according to the method described by Prince et al. [22] and Sanita et al. [8] . After incubation the diameter of hyaline zones around the colonies and the diameter of the colonies was measured using Image J software [23] . The phospholipase activity (Pl value) was measured in terms of the ratio of the diameter of the colony to the total diameter of colony plus the precipitation zone. Pl were also evaluated as follows: Pl < 0.64 (high), 0.64 ≤ Pl < 1 (low) and Pl = 1 (none).
Haemolysis (Hl) was evaluated using a blood plate assay [24] [25] . After incubation, the plates were measured using Image J software [23] . The presence of a translucent zone of haemolysis around the inoculum site, viewed with transmitted light, indicated positive haemolytic activity. Haemolysin activity (Hl value) was measured and categorised as follows: Hl < 0.64 (high), 0.64 ≤ Hl < 1 (low) and Hl = 1 (none).
Proteinase activity (Pt) determination was made by the agar plate method as previously described by Barros et al. [26] . The plates were incubated at 37°C for 72 h and the enzymatic activity was determined by the formation of a halo around the colony, measured in terms of the ratio of the diameter of the colony to the total diameter of colony plus zone of precipitation. The proteinase activity (Pt value) was measured with the aid of Image J software and categorised as follows: Pt< 0.64 (high), 0.64 ≤ Pt < 1 (low) and Pt = 1 (none) [23] .
Biofilm formation (BF). The assessment of the biofilm forming capacity of the yeasts was performed following protocols published by Pierce et al. [27] with some modifications. The method is based on inducing the formation of biofilms in 96-well microplates and on the metabolic capability of live yeast cells to reduce a tetrazolium salt (XTT) to water soluble coloured formazan compounds [28] . The colour intensity of the formazan solution was measured with a microplate reader.
The C. albicans SC5314 strain, which forms abundant biofilms with a complex structure, was used both for quality control and as a unit of measure for comparison. Isolates were classified as low biofilm formers (LBF) or high biofilm formers (HBF) if their biomass absorbance was less than the first quartile (Q 1 OD 570 = 0.366) or greater than the third quartile (Q 3 OD 570 = 1.286), respectively. The isolates in between the first and third quartile (Q 1 -Q 3 ) were defined as intermediate biofilm formers (IBF).
Descriptive statistics, chi-square test, oneway ANOVA, and Pearson's correlation coefficient were used to analyze the obtained data.
Results
In terms of C. albicans infection site, of the 301 samples, 57.47% were from superficial infections (SUP, n=173) like: vaginal discharge (n=39), vaginal discharge in pregnant women (n=29), pharyngeal exudate (n=4), onycomycosis (n=2), gastrointestinal tract (n=2), scraped lingual (n=5), oral sampling (n=32), oral sampling from patients with diabetes (n=6), oral sampling from pregnant women (n=4), oral sampling from HIV patients (n=26), oral sampling from denture patients (n=3), oral sampling from TBC patients (n=1), nail sample (n=1), balanitis sample (n=1), faeces samples (n=11), faeces samples from HIV patients (n=6), and colecistitis sample (n=1). C. albicans was sampled 20.59% from blood culture (BSI, n=62) and 21.92% of strains were from deep-seated life-threatening systemic infections (DEEP, n=66) like: urine (n=3), urine from HIV patients (n=1), respiratory tract (n=3), cerebrospinal fluid (n=1), bronchial aspirate (n=2), bronchial aspirate from TBC patients (n=15), sputum (n=26), sputum from TBC patients (n=8) and drain tube (n=7) ( Table 1) .
Genotype determination (G). C. albicans were classified into three different groups, based on the length of polymerase chain reaction (PCR) amplification product, namely genotypes A with 52.92%, B with 17.85%, respectively C, with 29.20% (Table 1) .
Resistogram (R). The 301 strains were grouped into 5 resistotypes ( Table 1 ). The majority were resistant to sodium selenite (A), boric acid (B), sodium periodate (D) and silver nitrate (E), but sensitive to cetrimide (-) (86.19%).
Phospholipase activity (Pl). C. albicans isolates presented low phospholipase activity (Pl) with values between 0.61 and 1 (Figure 1) . The low activity of phospholipases was observed in 7.76% of the isolates (Table 1) .
Haemolysis (Hl). The haemolytic activity of different C. albicans strains obtained from a variety of clinical sources (Figure 1 ) was evaluated. Most of the investigated strains presented low haemolytic activity (95.49%) ( Table 1) .
Proteinases (Pt). Most of the analyzed strains presented a low level of proteinases (61.73%), and the rest of the strains did not present any Pt (38.27%) (Table 1, Figure 1 ).
Biofilm formation (BF). Biofilm formation is heterogeneous, with isolates classified as either high or low biofilm formers (LBF and HBF) (Figure 1 ). Isolates were categorised as low biofilm formers (LBF) for 60.77% of the strains or high biofilm formers (HBF) for 1.92% if their biomass absorbance was less than the first quartile (Q 1 OD570 = 0.366) or greater than the third quartile (Q 3 OD570 = 1.286), respectively. Those isolates in between the first and third quartile (Q 1 -Q 3 ) were defined as intermediate biofilm formers (37.29%) ( Table 1) .
Statistical analysis. One-way ANOVA revealed significant effects of prevalence on biofilm formation (p = 0.0137) ( Table 2) . No other statistical significant effects were found between the analyzed parameters. The results of the chisquare test (Table 2) showed a significant positive association only between prevalence and resistograms (p = 0.0832).
There was a strong correlation between phospholipases and haemolytic activity (r = 0.563) and proteinases (r = 0.548) and also between haemolytic activity and proteinases (r = 0.886) ( Table 3) . No significant correlation was found between the genotype (A, B, C) and the infection site (p =0.449).
Discussions
Genotype determination (G). C. albicans strains converge to be genetically similar, when derived from similar population groups, in correlation with the immune condition, anatomic site or geographical location [28] . It was not proved that the virulence of C. albicans is related to genotypes. One study found that genotype A was more prevalent among invasive isolates and that genotype B and C were more common among none-invasive isolates (p<0.05) [29] . Also, Al-Karaawi et al. [28] reported that genotype A is the most predominant type in patients with oral Candida infections. Interestingly, the obtained results in the current study showed no significant correlation between the genotype (A, B, C) and the infection site (p =0.449, table 1). Moreover, our previous study showed a significant correlation between genotype and isolates from HIV patients (p<0.0001) (unpublished data) concluding that maybe C. albicans pathogenicity relies on a series of particular inherent and environmental factors mostly related to the host. Thus, for example, in order to facilitate the hyphae invasion, Candida has the ability to produce a variety of hydrolytic enzymes, such as proteases, lipases, phospholipases, esterase and phosphatases [25] . Resistogram (R). A direct comparison between data from the current study and the previously reported ones [20] [21] in terms of resistogram methods is difficult due to the chemical concentrations of the used compounds, the number of strains and their prevalence. To facilitate data analysis, data from the 301 tested strains were grouped into only 5 resistotypes. The obtained general results revealed that most of the strains (86.816%) were completely resistant to sodium selenite, boric acid, sodium periodate and silver nitrate, but showed an unexpected sensitivity to cetrimide (resistogram pattern AB_DE).
Phospholipase activity (Pl), and secreted aspartyl proteinases (SPA) are determinant of not only commensal colonization, but also for the pathogenic potential of these yeasts [30] . For example, some authors showed that enzymatic secretion vary for C. albicans isolates of different strain and origin [31] . C. albicans secretes phospholipases A, B and C, which are considered to be virulence factors, being associated with the damage, adherence and penetration of the host cells [32] .
Literature reports showed that 30-100% of the oral isolates produced phospholipases, with variable degree of enzymatic activity, due to the origin of the isolates, the phenotypic variability or the variation in the method employed. [23] . Vidotto et al. [33] did not find a relationship be- tween phospholipase activity and genotype, regardless of the body site where the strains were collected. Their results are confirmed by this study. Proteinase activity (Pt). C. albicans has various secreted hydrolytic enzymes of which secreted aspartyl proteinases contribute to the pathogenesis of candidiasis. Their role in pathogenicity is that the enzymes have the ability to degrade a number of important host factors [34] . However, some of the analyzed C. albicans strains proved to have a low level of proteinases and the rest of the strains did not present any proteinase activity.
Haemolysis (Hl) is known to facilitate iron acquisition from host erythrocytes, being an important virulence factor that contributes to Candida ssp. dissemination [24] . Watanabe et al. [35] stipulated that the beta haemolysin in C. albicans is a cell wall mannoprotein. Luo et al. [25] noticed that 6 of 14 Candida species tested did not produce beta-haemolysis although mannoprotein is a universal component of the Candida cell wall, maybe due to the variation of the cell wall mannoprotein content in different Candida species. It seems that the absence of glucose in the medium altered the sugar moiety of the mannoprotein leading to the loss of beta-haemolytic activities [24] . Even if the previous studies prove that haemolysis plays an important role in C. albicans disseminations, most of the investigated strains presented low haemolytic activity (95.49%).
Biofilm formation (BF). The ability of the fungal cells to form biofilms is the main factor that blocks the antifungal activity [36] . Candidaemia is often associated with the ability of Candida to form biofilms on indwelling medical devices such as central venous catheters and prosthesis [37] . A biofilm is a structural microbial community attached to a surface and packed with a self-produced extra-cellular matrix [38] . Biofilms are defined by resistance to antibiotics and higher drug concentrations are required [39] [40] . Biofilm formations vary between Candida isolates and categorizing them may help to predict how these will behave clinically [28] .
There is a fundamental gap in understanding exactly what drives biofilm formation and its clinical implications. We aimed to evaluate and categorize C. albicans biofilms into distinct levels of biofilm formation. Our isolates were categorised mostly as low biofilm formers (LBF) for 60.77%, proving that their pathogenicity relies not only on their properties to form biofilms, but maybe on a mixture of factors related to their phenotype and definitely related to the host characteristics.
In conclusion, all the isolated and analyzed strains of C. albicans had strain-dependent variable levels of enzymatic activity, and they were not all biofilm producers. There were only a few significant statistical correlations in the studied virulence factors, including genotype and prevalence. Although much progress has been made in understanding the phenotypic and genotypic profile of C. albicans, still little is known regarding their interaction with the host.
